253 related articles for article (PubMed ID: 20354171)
1. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation.
Shono Y; Ueha S; Wang Y; Abe J; Kurachi M; Matsuno Y; Sugiyama T; Nagasawa T; Imamura M; Matsushima K
Blood; 2010 Jul; 115(26):5401-11. PubMed ID: 20354171
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.
Shono Y; Shiratori S; Kosugi-Kanaya M; Ueha S; Sugita J; Shigematsu A; Kondo T; Hashimoto D; Fujimoto K; Endo T; Nishio M; Hashino S; Matsuno Y; Matsushima K; Tanaka J; Imamura M; Teshima T
Biol Blood Marrow Transplant; 2014 Apr; 20(4):495-500. PubMed ID: 24374213
[TBL] [Abstract][Full Text] [Related]
3. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
[TBL] [Abstract][Full Text] [Related]
4. Infusion of endothelial progenitor cells accelerates hematopoietic and immune reconstitution, and ameliorates the graft-versus-host disease after hematopoietic stem cell transplantation.
Zeng L; Chen C; Song G; Yan Z; Xu S; Jia L; Ding S; Cao J; Chen W; Cheng H; Li Z; Sang W; Wang L; Li Y; Xu K
Cell Biochem Biophys; 2012 Dec; 64(3):213-22. PubMed ID: 22806343
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of bone marrow vascular niche in acute graft-versus-host disease after MHC-haploidentical bone marrow transplantation.
Yao Y; Song X; Cheng H; Tang G; Hu X; Zhou H; Wang J
PLoS One; 2014; 9(8):e104607. PubMed ID: 25119573
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.
Mensen A; Jöhrens K; Anagnostopoulos I; Demski S; Oey M; Stroux A; Hemmati P; Westermann J; Blau O; Wittenbecher F; Movassaghi K; Szyska M; Thomas S; Dörken B; Scheibenbogen C; Arnold R; Na IK
Blood; 2014 Aug; 124(6):963-72. PubMed ID: 24833353
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.
Delisle JS; Gaboury L; Bélanger MP; Tassé E; Yagita H; Perreault C
Blood; 2008 Sep; 112(5):2111-9. PubMed ID: 18552211
[TBL] [Abstract][Full Text] [Related]
8. Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation.
Shahin K; Mattar Z; Silveira P; Hsu WH; Bendall L; Hart D; Bradstock KF
Transplantation; 2017 Nov; 101(11):2695-2704. PubMed ID: 28319565
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression.
Mori T; Nishimura T; Ikeda Y; Hotta T; Yagita H; Ando K
Blood; 1998 Jul; 92(1):101-7. PubMed ID: 9639505
[TBL] [Abstract][Full Text] [Related]
10. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
[TBL] [Abstract][Full Text] [Related]
11. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation.
Drobyski WR; Keever CA; Hanson GA; McAuliffe T; Griffith OW
Blood; 1994 Oct; 84(7):2363-73. PubMed ID: 7522627
[TBL] [Abstract][Full Text] [Related]
13. Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors.
Sheng-Tanner X; McKerlie C; Spaner D
Transplantation; 2000 Dec; 70(12):1683-93. PubMed ID: 11152097
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?
Müskens KF; Lindemans CA; Belderbos ME
Cells; 2021 Aug; 10(8):. PubMed ID: 34440819
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice.
Saito H; Ichii M; Toda J; Kitai Y; Muromoto R; Kashiwakura JI; Saitoh K; Tanimura A; Yokota T; Shibayama H; Matsuda T; Oritani K; Kanakura Y; Hosen N
Biochem Biophys Res Commun; 2021 Jan; 537():118-124. PubMed ID: 33388414
[TBL] [Abstract][Full Text] [Related]
18. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.
Shizuru JA; Jerabek L; Edwards CT; Weissman IL
Biol Blood Marrow Transplant; 1996 Feb; 2(1):3-14. PubMed ID: 9078349
[TBL] [Abstract][Full Text] [Related]
20. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
